Business Context and Reporting Period
This Form 6-K filing by Brainsway Ltd. reports on the Annual General Meeting of Shareholders held on March 4, 2021. The company is a foreign private issuer based in Jerusalem, Israel, and files annual reports on Form 20-F.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance resolutions approved by shareholders.
Material Changes and Corporate Actions
- Auditor Appointment: Shareholders approved the appointment of Kost Forer Gabbay & Kasierer (Ernst & Young Global) as independent auditors for 2020.
- Board Re-election: Dr. David Zacut was re-elected as Chairman, Mr. Avner Hagai as Vice Chairman, and five other directors were re-elected to the Board.
- Option Repricing: Independent directors' existing options were repriced to an exercise price of $4.675 per share ($9.35 per ADS), matching the closing price on January 25, 2021.
- Executive Compensation: The CEO, Christopher von Jako, was granted 180,000 Restricted Share Units (RSUs) with a 4-year vesting schedule. This replaces three previously committed annual grants of 60,000 RSUs each.
- Capital Increase: Authorized share capital was increased by 25,000,000 ordinary shares, raising the total from 35,000,000 to 60,000,000 shares.
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, future outlook, specific risks, contingencies, or unusual items. It serves strictly as a record of shareholder resolutions.
Key Facts for Investor Verification
- Verify the impact of the option repricing on dilution and future compensation expenses.
- Confirm the vesting criteria and timeline for the 180,000 RSUs granted to the CEO.
- Review the updated Articles of Association regarding the increased authorized share capital.
- Check subsequent filings for the actual compensation paid to the newly appointed auditors for 2020.